VP of Marketing (AI-Native & Autonomous Operations)

BenchSci is a technology company that develops artificial intelligence and machine learning software to accelerate biological and biomedical research by making experimental reagent and protocol information discoverable and actionable. The company’s core offering is an AI-powered reagent search and decision-support platform that helps life science researchers find validated reagents (particularly antibodies), interpret how reagents have been used in peer-reviewed experiments, and choose appropriate reagents and experimental conditions based on published evidence. BenchSci’s technology extracts and organizes experimental data from the scientific literature—figures, methods sections, and reagent lists—so researchers can locate instances of specific reagents being used in relevant assay types, species, cell lines, and experimental contexts. BenchSci’s primary business activities center on the development of automated knowledge extraction pipelines and enterprise software tailored for research scientists, pharmaceutical companies, biotechnology firms, and academic laboratories. The company applies computer vision, natural language processing (NLP), and specialized machine learning models to parse millions of figures and text passages from peer-reviewed articles, mapping entities such as antibodies, genes, proteins, assays, and experimental conditions to metadata that supports evidence-based reagent selection. By converting unstructured literature content into structured, searchable data, BenchSci aims to reduce time wasted on reagent selection and reduce experimental failure due to poor reagent choice or ambiguous reporting. Key products and services delivered by BenchSci include a searchable reagent and experimental-evidence platform (often described as a reagent search engine or AI platform for life sciences) and enterprise integrations that embed literature-derived reagent intelligence into organizational workflows. The platform enables researchers to search by target (e.g., a specific protein), filter results by experimental technique (e.g., western blot, immunohistochemistry), species, cell line, antibody clone, vendor, and reported performance, and then view the original figures and excerpted methods where that reagent was used. This visibility into how reagents have been used in published experiments allows users to assess the experimental context, reported concentrations, dilutions, and other protocol details that are commonly buried in articles. The product is positioned as a tool to improve experimental reproducibility and to accelerate project timelines by surfacing high-quality, literature-backed reagent options. BenchSci operates as a software-as-a-service (SaaS) provider for customers in the life sciences sector, offering enterprise-level deployments and user management features that support teams at pharmaceutical and biotechnology companies, diagnostics developers, and research institutions. In addition to individual researcher access, BenchSci’s offering can be integrated into procurement and vendor-selection workflows, enabling organizations to standardize reagent selection on evidence-based choices and to streamline interactions with reagent suppliers. The company also maintains relationships with reagent vendors and publishers to enable linking between product catalogs and literature evidence where appropriate. From a technology perspective, BenchSci emphasizes the use of deep learning, computer vision for extracting data from figures and images, and NLP to interpret methods and reagents mentioned in free text. The company’s platform aggregates and indexes extracted data to create searchable records that link back to source publications; this record-level evidence helps users quickly validate claims about reagent performance and provenance. BenchSci’s systems are trained on a large corpus of biomedical publications and are tuned to recognize domain-specific entities (e.g., antibody clone names, catalogue numbers, conjugates, host species) and experimental parameters relevant to wet-lab workflows. BenchSci’s target users include bench scientists running preclinical experiments, core facilities and lab managers responsible for reagent procurement, and research leaders at pharmaceutical and biotech companies focused on translational research and discovery. The platform is designed to complement laboratory expertise by reducing the time required to survey the literature for reagent use-cases, helping teams avoid common pitfalls such as purchasing reagents with insufficient supporting evidence or selecting reagents incompatible with planned assay conditions. On the commercial side, BenchSci supports enterprise customers with account services, training, and integration assistance. The company’s value proposition centers on lowering the rate of wasted experiments and accelerating experimental design cycles by surfacing evidence-backed reagent choices. BenchSci positions its product as part of a broader trend in life sciences toward digitization of experimental knowledge and the application of AI to unlock insights from the vast and growing body of published research. BenchSci is categorized at the intersection of software, artificial intelligence, and life sciences: it is a technology company focused on biomedical research enablement rather than a reagent manufacturer. Its offerings address pain points in experimental reproducibility and literature discovery, and its product set and services are oriented toward improving the efficiency and reliability of preclinical and translational research workflows. BenchSci’s platform is typically used by research organizations that require curated, evidence-linked reagent information to support high-throughput project timelines and rigorous experimental standards.